Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Jacob Snapp

Advertisement

Articles by Jacob Snapp

Supply Chain Analytics: Pharma’s Next Big Bet

ByJacob Snapp,Srihari Rangarajan
January 17th 2015

Pharmaceutical Executive

Examining a new three-part formula to enable the supply chain function to manage market pressures while delivering on the bottom line.

Advertisement

Latest Updated Articles

  • Supply Chain Analytics: Pharma’s Next Big Bet
    Supply Chain Analytics: Pharma’s Next Big Bet

    January 17th 2015



Advertisement
Advertisement

Trending on PharmExec

1

Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report

2

Ultragenyx Shares Drop Following Failed Phase III Clinical Trial

3

FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults

4

What Moments in FDA’s Review Process Should Patients and Providers be Watching Closely?

5

Your Questions Answered: The Biggest Pharma and Biotech Stories This Week

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us